Emma Wheatley is Director, Access and Private Partnerships at CEPI.
Emma joined CEPI in 2017 and has served as Director, Access and Private Partnerships since January 2022. Responsible for the Equitable Access Policy and business development at CEPI, Emma and her team bridge the demand for accessible, affordable medical countermeasures with the ability to create a set of interoperable partnerships that together enable equitable access. Her particular interest is in the business models that make those partnerships sustainable and the systemic drivers that enable or undermine those models.
She has over 20 years’ experience of strategic transactions and collaborations in the life science industry. Her work enabling access to vaccines for low and middle income countries started in 2007 with a public private partnership at the University of Oxford for a Tuberculosis vaccine. More recently, as Vice President Legal Affairs and Deputy General Counsel at Emergent Biosolutions, Emma spent several years advising on strategy and structure of transactions related to outbreak preparedness, BARDA’s CIADM programme and stockpiling for national security.
